ℹ️
🇬🇧
Search
Search for people relevant for "Biomarker"
Biomarker
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. Martin Svatoň Ph.D.
Academic staff at Faculty of Medicine in Pilsen
82 publications
Publications
publication
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
2018 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
publication
Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy
2018 |
Faculty of Medicine in Pilsen
publication
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
2017 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
2016 |
Faculty of Medicine in Pilsen, Faculty of Science, First Faculty of Medicine
publication
Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy
2016 |
Faculty of Medicine in Pilsen, First Faculty of Medicine
publication
Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC
2016 |
Faculty of Medicine in Pilsen, Faculty of Science
publication
Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
2014 |
Faculty of Medicine in Pilsen
publication
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
2023 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
publication
Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC
2023 |
Faculty of Medicine in Pilsen, Faculty of Science, Central Library of Charles University
publication
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer
2023 |
Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Load more publications (72)
Loading network view...